Xu ZG - Search Results

1

Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.

Xu ZG, Yoo TH, Ryu DR, Cheon Park H, Ha SK, Han DS, Adler SG, Natarajan R, Kang SW. Xu ZG, et al. Kidney Int. 2005 Mar;67(3):944-52. doi: 10.1111/j.1523-1755.2005.00158.x. Kidney Int. 2005. PMID: 15698433 Free article.

2

High glucose activates the p38 MAPK pathway in cultured human peritoneal mesothelial cells.

Xu ZG, Kim KS, Park HC, Choi KH, Lee HY, Han DS, Kang SW. Xu ZG, et al. Kidney Int. 2003 Mar;63(3):958-68. doi: 10.1046/j.1523-1755.2003.00836.x. Kidney Int. 2003. PMID: 12631076 Free article.

3

Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade.

Kim DK, Yoo TH, Ryu DR, Xu ZG, Kim HJ, Choi KH, Lee HY, Han DS, Kang SW. Kim DK, et al. Among authors: xu zg. Perit Dial Int. 2004 Sep-Oct;24(5):424-32. Perit Dial Int. 2004. PMID: 15490981

4

Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells.

Kim YS, Xu ZG, Reddy MA, Li SL, Lanting L, Sharma K, Adler SG, Natarajan R. Kim YS, et al. Among authors: xu zg. J Am Soc Nephrol. 2005 Feb;16(2):352-62. doi: 10.1681/ASN.2004070568. Epub 2004 Dec 22. J Am Soc Nephrol. 2005. PMID: 15615821

5

P-Cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies.

Xu ZG, Ryu DR, Yoo TH, Jung DS, Kim JJ, Kim HJ, Choi HY, Kim JS, Adler SG, Natarajan R, Han DS, Kang SW. Xu ZG, et al. Nephrol Dial Transplant. 2005 Mar;20(3):524-31. doi: 10.1093/ndt/gfh642. Epub 2005 Jan 12. Nephrol Dial Transplant. 2005. PMID: 15647309

6

Upregulation of angiotensin II type 1 receptor, inflammatory mediators, and enzymes of arachidonate metabolism in obese Zucker rat kidney: reversal by angiotensin II type 1 receptor blockade.

Xu ZG, Lanting L, Vaziri ND, Li Z, Sepassi L, Rodriguez-Iturbe B, Natarajan R. Xu ZG, et al. Circulation. 2005 Apr 19;111(15):1962-9. doi: 10.1161/01.CIR.0000161831.07637.63. Circulation. 2005. PMID: 15837950

7

Role of AT-1 receptor in regulation of vascular MCP-1, IL-6, PAI-1, MAP kinase, and matrix expressions in obesity.

Vaziri ND, Xu ZG, Shahkarami A, Huang KT, Rodríguez-Iturbe B, Natarajan R. Vaziri ND, et al. Among authors: xu zg. Kidney Int. 2005 Dec;68(6):2787-93. doi: 10.1111/j.1523-1755.2005.00750.x. Kidney Int. 2005. PMID: 16316354 Free article.

8

Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells.

Reddy MA, Li SL, Sahar S, Kim YS, Xu ZG, Lanting L, Natarajan R. Reddy MA, et al. Among authors: xu zg. J Biol Chem. 2006 May 12;281(19):13685-13693. doi: 10.1074/jbc.M511425200. Epub 2006 Mar 21. J Biol Chem. 2006. PMID: 16551628 Free article.

9

Role of the Akt/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease.

Kato M, Yuan H, Xu ZG, Lanting L, Li SL, Wang M, Hu MC, Reddy MA, Natarajan R. Kato M, et al. Among authors: xu zg. J Am Soc Nephrol. 2006 Dec;17(12):3325-35. doi: 10.1681/ASN.2006070754. Epub 2006 Nov 2. J Am Soc Nephrol. 2006. PMID: 17082237

10

Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.

Guha M, Xu ZG, Tung D, Lanting L, Natarajan R. Guha M, et al. Among authors: xu zg. FASEB J. 2007 Oct;21(12):3355-68. doi: 10.1096/fj.06-6713com. Epub 2007 Jun 6. FASEB J. 2007. PMID: 17554073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

432 results

Search Page

Filters